{"transactions":[{"id":701313,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-07-30T00:07:25.000Z","date":"2026-07-29","kind":"sale","planned":false,"acquired":false,"shares":148517,"price":33.3153,"value":4947888.4101,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.82 to $33.77, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."}],"balance_after":2572441,"source":{"system":"sec-edgar","filing":"0001193125-26-324448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526324448/ownership.xml","form_type":"4"}},{"id":701312,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-07-30T00:07:25.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":221667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on July 28, 2026 upon the achievement of a non-financial performance goal."}],"balance_after":2720958,"source":{"system":"sec-edgar","filing":"0001193125-26-324448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526324448/ownership.xml","form_type":"4"}},{"id":949996,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":176300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":176300,"derivative":{"exercise_price":35.42,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":176300},"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":949995,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":6400,"price":35.0661,"value":224423.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.88 to $35.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2499291,"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":949994,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":41276,"price":34.2184,"value":1412398.6784,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2505691,"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":949993,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":53279,"price":33.3765,"value":1778266.5435,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.87 to $33.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2546967,"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":949992,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":132454,"price":32.2907,"value":4277032.3778,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards that vested on January 3, 2026 and the performance restricted stock unit awards described in Footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.87 to $32.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2600246,"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":949991,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":224080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on January 2, 2026. upon the achievement of a non-financial performance goal and a second performance restricted stock unit award that was granted on January 3, 2025, 1.665% of which vested on January 2, 2026, upon the partial achievement of a non-financial performance goal."}],"balance_after":2732700,"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":949990,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-01-06T01:28:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":78400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,111 shares acquired on May 20, 2024 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":2508620,"source":{"system":"sec-edgar","filing":"0001193125-26-003113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312526003113/ownership.xml","form_type":"4"}},{"id":1012432,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-10-28T23:48:53.000Z","date":"2025-10-28","kind":"sale","planned":false,"acquired":false,"shares":38989,"price":35.0079,"value":1364923.0131,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.48, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."}],"balance_after":2419109,"source":{"system":"sec-edgar","filing":"0001193125-25-254299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312525254299/ownership.xml","form_type":"4"}},{"id":1012431,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-10-28T23:48:53.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":70084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on October 27, 2025 upon the achievement of a non-financial performance goal and 15% of which vested also on October 27, 2025 upon the partial achievement of a non-financial performance goal."}],"balance_after":2458098,"source":{"system":"sec-edgar","filing":"0001193125-25-254299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000119312525254299/ownership.xml","form_type":"4"}},{"id":1091833,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-07-03T19:31:13.000Z","date":"2025-07-03","kind":"sale","planned":false,"acquired":false,"shares":26889,"price":27.8044,"value":747632.5116,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to  the performance restricted stock unit award described in Footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.70 to $27.86, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."}],"balance_after":2388014,"source":{"system":"sec-edgar","filing":"0000950170-25-093793","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025093793/ownership.xml","form_type":"4"}},{"id":1091832,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-07-03T19:31:13.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":48333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on July 2, 2025 upon the achievement of a non-financial performance goal."}],"balance_after":2414903,"source":{"system":"sec-edgar","filing":"0000950170-25-093793","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025093793/ownership.xml","form_type":"4"}},{"id":1309713,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T01:16:00.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":78300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":78300,"derivative":{"exercise_price":42.89,"exercise_date":"2026-01-03","expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":78300},"source":{"system":"sec-edgar","filing":"0000950170-25-002487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002487/ownership.xml","form_type":"4"}},{"id":1309712,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:16:00.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":19000,"price":43.3169,"value":823021.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards and certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.19 to $43.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2366570,"source":{"system":"sec-edgar","filing":"0000950170-25-002487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002487/ownership.xml","form_type":"4"}},{"id":1309711,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:16:00.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":175490,"price":42.6838,"value":7490580.062,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain restricted stock unit awards and certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.19 to $43.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2385570,"source":{"system":"sec-edgar","filing":"0000950170-25-002487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002487/ownership.xml","form_type":"4"}},{"id":1309710,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:16:00.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":163333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2024, 33.33% of which vested on January 3, 2025 upon the achievement of a non-financial performance goal."}],"balance_after":2561060,"source":{"system":"sec-edgar","filing":"0000950170-25-002487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002487/ownership.xml","form_type":"4"}},{"id":1309709,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2025-01-07T01:16:00.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":92800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2024 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":2397727,"source":{"system":"sec-edgar","filing":"0000950170-25-002487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017025002487/ownership.xml","form_type":"4"}},{"id":1401390,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-21T01:20:57.000Z","date":"2024-09-20","kind":"exercise","planned":true,"acquired":false,"shares":166130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on each anniversary of the grant date."}],"balance_after":65000,"derivative":{"exercise_price":7.77,"exercise_date":"2021-01-03","expiration_date":"2030-01-03","underlying":"Common Stock","underlying_shares":166130},"source":{"system":"sec-edgar","filing":"0000950170-24-108576","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024108576/ownership.xml","form_type":"4"}},{"id":1401389,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-09-21T01:20:57.000Z","date":"2024-09-20","kind":"sale","planned":true,"acquired":false,"shares":200,"price":71.985,"value":14397.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.97 to $72.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2304927,"source":{"system":"sec-edgar","filing":"0000950170-24-108576","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024108576/ownership.xml","form_type":"4"}},{"id":1401388,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-09-21T01:20:57.000Z","date":"2024-09-20","kind":"sale","planned":true,"acquired":false,"shares":119874,"price":71.1501,"value":8529047.0874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.90 to $71.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2305127,"source":{"system":"sec-edgar","filing":"0000950170-24-108576","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024108576/ownership.xml","form_type":"4"}},{"id":1401387,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-09-21T01:20:57.000Z","date":"2024-09-20","kind":"sale","planned":true,"acquired":false,"shares":96056,"price":70.4288,"value":6765108.8128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.90 to $70.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2425001,"source":{"system":"sec-edgar","filing":"0000950170-24-108576","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024108576/ownership.xml","form_type":"4"}},{"id":1401386,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-09-21T01:20:57.000Z","date":"2024-09-20","kind":"exercise","planned":true,"acquired":true,"shares":166130,"price":7.77,"value":1290830.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."}],"balance_after":2521057,"source":{"system":"sec-edgar","filing":"0000950170-24-108576","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024108576/ownership.xml","form_type":"4"}},{"id":1424981,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T23:23:58.000Z","date":"2024-08-21","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each anniversary of the grant date."}],"balance_after":231130,"derivative":{"exercise_price":7.77,"exercise_date":"2021-01-03","expiration_date":"2030-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-099982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024099982/ownership.xml","form_type":"4"}},{"id":1424980,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-08-22T23:23:58.000Z","date":"2024-08-21","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":69.9,"value":69900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."}],"balance_after":2354927,"source":{"system":"sec-edgar","filing":"0000950170-24-099982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024099982/ownership.xml","form_type":"4"}},{"id":1424979,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-08-22T23:23:58.000Z","date":"2024-08-21","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":7.77,"value":7770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."}],"balance_after":2355927,"source":{"system":"sec-edgar","filing":"0000950170-24-099982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024099982/ownership.xml","form_type":"4"}},{"id":1428816,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-20T00:13:31.000Z","date":"2024-08-19","kind":"exercise","planned":true,"acquired":false,"shares":112870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on each anniversary of the grant date."}],"balance_after":232130,"derivative":{"exercise_price":7.77,"exercise_date":"2021-01-03","expiration_date":"2030-01-03","underlying":"Common Stock","underlying_shares":112870},"source":{"system":"sec-edgar","filing":"0000950170-24-098803","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024098803/ownership.xml","form_type":"4"}},{"id":1428815,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-08-20T00:13:31.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":11296,"price":67.1206,"value":758194.2976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.9302 to $67.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2354927,"source":{"system":"sec-edgar","filing":"0000950170-24-098803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024098803/ownership.xml","form_type":"4"}},{"id":1428814,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-08-20T00:13:31.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":31442,"price":66.3705,"value":2086821.261,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.93 to $66.9091, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2366223,"source":{"system":"sec-edgar","filing":"0000950170-24-098803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024098803/ownership.xml","form_type":"4"}},{"id":1428813,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-08-20T00:13:31.000Z","date":"2024-08-19","kind":"sale","planned":true,"acquired":false,"shares":70132,"price":65.3267,"value":4581492.1244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.90 to $65.8919, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2397665,"source":{"system":"sec-edgar","filing":"0000950170-24-098803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024098803/ownership.xml","form_type":"4"}},{"id":1428812,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-08-20T00:13:31.000Z","date":"2024-08-19","kind":"exercise","planned":true,"acquired":true,"shares":112870,"price":7.77,"value":876999.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on May 8, 2024 by the Reporting Person."}],"balance_after":2467797,"source":{"system":"sec-edgar","filing":"0000950170-24-098803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024098803/ownership.xml","form_type":"4"}},{"id":1445105,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-30","kind":"sale","planned":false,"acquired":false,"shares":30417,"price":58.78,"value":1787911.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis soley to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.46 to $59.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2354927,"source":{"system":"sec-edgar","filing":"0000950170-24-088544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088544/ownership.xml","form_type":"4"}},{"id":1445104,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-30","kind":"sale","planned":false,"acquired":false,"shares":19501,"price":57.81,"value":1127352.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis soley to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.46 to $58.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2385344,"source":{"system":"sec-edgar","filing":"0000950170-24-088544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088544/ownership.xml","form_type":"4"}},{"id":1445103,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-30","kind":"sale","planned":false,"acquired":false,"shares":65941,"price":56.95,"value":3755339.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were automatically sold on a non-discretionary basis soley to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.46 to $57.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2404845,"source":{"system":"sec-edgar","filing":"0000950170-24-088544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088544/ownership.xml","form_type":"4"}},{"id":1445102,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":163333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2024, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":2470786,"source":{"system":"sec-edgar","filing":"0000950170-24-088544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088544/ownership.xml","form_type":"4"}},{"id":1445101,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-07-31T20:05:07.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":2307453,"source":{"system":"sec-edgar","filing":"0000950170-24-088544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024088544/ownership.xml","form_type":"4"}},{"id":1559217,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-28T00:51:31.000Z","date":"2024-03-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":153948,"price":83.34,"value":12830026.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon\nthe vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":2266453,"source":{"system":"sec-edgar","filing":"0001209191-24-005117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005117/doc4.xml","form_type":"4"}},{"id":1559216,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-28T00:51:31.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":221667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on March 27, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":2420401,"source":{"system":"sec-edgar","filing":"0001209191-24-005117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124005117/doc4.xml","form_type":"4"}},{"id":1602355,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-05T00:54:02.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":162815,"price":85.22,"value":13875094.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon\nthe vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":2198734,"source":{"system":"sec-edgar","filing":"0001209191-24-004233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124004233/doc4.xml","form_type":"4"}},{"id":1602354,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-03-05T00:54:02.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":221667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on March 1, 2024 upon the achievement of a non-financial performance goal."}],"balance_after":2361549,"source":{"system":"sec-edgar","filing":"0001209191-24-004233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124004233/doc4.xml","form_type":"4"}},{"id":1651179,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-10T01:59:57.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":45000,"price":29.9,"value":1345500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2139882,"source":{"system":"sec-edgar","filing":"0001209191-24-003068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003068/doc4.xml","form_type":"4"}},{"id":1653013,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.65,"exercise_date":"2019-01-19","expiration_date":"2028-01-19","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653012,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":34931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.23,"exercise_date":"2017-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":34931},"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653011,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":14148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.23,"exercise_date":"2018-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":14148},"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653010,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":28.9,"value":1156000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2184882,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653009,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":27.45,"value":1098000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2224882,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653008,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":80000,"price":26.95,"value":2156000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2264882,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653007,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":25.95,"value":1557000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2344882,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653006,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":140000,"price":4.65,"value":651000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2404882,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653005,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":49079,"price":25.75,"value":1263784.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2264882,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1653004,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-09T00:40:13.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":49079,"price":1.23,"value":60367.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2313961,"source":{"system":"sec-edgar","filing":"0001209191-24-003010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124003010/doc4.xml","form_type":"4"}},{"id":1664811,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-01T01:39:53.000Z","date":"2024-01-31","kind":"exercise","planned":true,"acquired":false,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":14148,"derivative":{"exercise_price":1.23,"exercise_date":"2018-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-24-002512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002512/doc4.xml","form_type":"4"}},{"id":1664810,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-01T01:39:53.000Z","date":"2024-01-31","kind":"sale","planned":true,"acquired":false,"shares":45000,"price":24.95,"value":1122750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2264882,"source":{"system":"sec-edgar","filing":"0001209191-24-002512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002512/doc4.xml","form_type":"4"}},{"id":1664809,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-01T01:39:53.000Z","date":"2024-01-31","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":24.45,"value":978000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2309882,"source":{"system":"sec-edgar","filing":"0001209191-24-002512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002512/doc4.xml","form_type":"4"}},{"id":1664808,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-02-01T01:39:53.000Z","date":"2024-01-31","kind":"exercise","planned":true,"acquired":true,"shares":85000,"price":1.23,"value":104550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2349882,"source":{"system":"sec-edgar","filing":"0001209191-24-002512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002512/doc4.xml","form_type":"4"}},{"id":1666256,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T02:05:12.000Z","date":"2024-01-30","kind":"exercise","planned":true,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":99148,"derivative":{"exercise_price":1.23,"exercise_date":"2018-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-24-002458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002458/doc4.xml","form_type":"4"}},{"id":1666255,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-31T02:05:12.000Z","date":"2024-01-30","kind":"sale","planned":true,"acquired":false,"shares":35000,"price":23.95,"value":838250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2264882,"source":{"system":"sec-edgar","filing":"0001209191-24-002458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002458/doc4.xml","form_type":"4"}},{"id":1666254,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-31T02:05:12.000Z","date":"2024-01-30","kind":"exercise","planned":true,"acquired":true,"shares":35000,"price":1.23,"value":43050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023."}],"balance_after":2299882,"source":{"system":"sec-edgar","filing":"0001209191-24-002458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124002458/doc4.xml","form_type":"4"}},{"id":1684668,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-08T21:45:30.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":1666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on February 4, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":1666,"derivative":{"exercise_price":1.33,"expiration_date":"2034-01-04","underlying":"Common Stock","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001104659-24-002384","document":"tm242318-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000110465924002384/tm242318-2_4seq1.xml","form_type":"4"}},{"id":1686959,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-05T02:37:33.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":360000,"derivative":{"exercise_price":17.4,"exercise_date":"2025-01-03","expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001209191-24-000931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000931/doc4.xml","form_type":"4"}},{"id":1686958,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:37:33.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":39552,"price":18.58,"value":734876.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":2264882,"source":{"system":"sec-edgar","filing":"0001209191-24-000931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000931/doc4.xml","form_type":"4"}},{"id":1686957,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:37:33.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":106115,"price":17.4,"value":1846401.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":2304434,"source":{"system":"sec-edgar","filing":"0001209191-24-000931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000931/doc4.xml","form_type":"4"}},{"id":1686956,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:37:33.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":2410549,"source":{"system":"sec-edgar","filing":"0001209191-24-000931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000931/doc4.xml","form_type":"4"}},{"id":1686955,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:37:33.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":108525,"price":17.4,"value":1888335.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":2250549,"source":{"system":"sec-edgar","filing":"0001209191-24-000931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000931/doc4.xml","form_type":"4"}},{"id":1686954,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2024-01-05T02:37:33.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 33.33% of which vested on January 3, 2024 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,421 shares acquired on May 19, 2023 and 4,690 shares acquired on November 20, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":2359074,"source":{"system":"sec-edgar","filing":"0001209191-24-000931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919124000931/doc4.xml","form_type":"4"}},{"id":1909940,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-05-01T23:03:26.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":45000,"price":22.45,"value":1010250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2197963,"source":{"system":"sec-edgar","filing":"0001209191-23-026356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123026356/doc4.xml","form_type":"4"}},{"id":1915461,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-21T23:29:11.000Z","date":"2023-04-19","kind":"sale","planned":false,"acquired":false,"shares":35000,"price":21.45,"value":750750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2242963,"source":{"system":"sec-edgar","filing":"0001209191-23-025277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123025277/doc4.xml","form_type":"4"}},{"id":1917849,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T23:09:19.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on each anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.15,"exercise_date":"2017-03-04","expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-024724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024724/doc4.xml","form_type":"4"}},{"id":1917848,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-18T23:09:19.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":155000,"price":20.4501,"value":3169765.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2277963,"source":{"system":"sec-edgar","filing":"0001209191-23-024724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024724/doc4.xml","form_type":"4"}},{"id":1917847,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-18T23:09:19.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":true,"shares":125000,"price":2.15,"value":268750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2432963,"source":{"system":"sec-edgar","filing":"0001209191-23-024724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024724/doc4.xml","form_type":"4"}},{"id":1920148,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-13T21:14:18.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":54336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":0,"derivative":{"exercise_price":1.88,"exercise_date":"2016-03-14","expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":54336},"source":{"system":"sec-edgar","filing":"0001209191-23-024228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024228/doc4.xml","form_type":"4"}},{"id":1920147,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-13T21:14:18.000Z","date":"2023-04-13","kind":"sale","planned":false,"acquired":false,"shares":79336,"price":18.45,"value":1463749.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2307963,"source":{"system":"sec-edgar","filing":"0001209191-23-024228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024228/doc4.xml","form_type":"4"}},{"id":1920146,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-13T21:14:18.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":54336,"price":1.88,"value":102151.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2387299,"source":{"system":"sec-edgar","filing":"0001209191-23-024228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123024228/doc4.xml","form_type":"4"}},{"id":1931880,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":67970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested upon grant and 25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.49,"exercise_date":"2016-05-04","expiration_date":"2025-05-04","underlying":"Common Stock","underlying_shares":67970},"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931879,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":19530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested upon grant and 25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":67970,"derivative":{"exercise_price":9.49,"exercise_date":"2016-05-04","expiration_date":"2025-05-04","underlying":"Common Stock","underlying_shares":19530},"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931878,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":false,"shares":115852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on each one year anniversary of the grant date."}],"balance_after":134148,"derivative":{"exercise_price":1.23,"exercise_date":"2018-01-05","expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":115852},"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931877,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":200000,"price":17.57,"value":3514000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":2332963,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931876,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 66.67% of which vested on April 3, 2023 upon the achievement of two non-financial performance goals."}],"balance_after":2532963,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931875,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":22000,"price":17.85,"value":392700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2232963,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931874,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":false,"shares":67970,"price":17.45,"value":1186076.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2254963,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931873,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":67970,"price":9.49,"value":645035.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2322933,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931872,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":65382,"price":17.45,"value":1140915.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2254963,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931871,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":88000,"price":16.95,"value":1491600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2320345,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931870,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":19530,"price":9.49,"value":185339.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2408345,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":1931869,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-04-03T23:26:43.000Z","date":"2023-03-30","kind":"exercise","planned":false,"acquired":true,"shares":115852,"price":1.23,"value":142497.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person"}],"balance_after":2388815,"source":{"system":"sec-edgar","filing":"0001209191-23-022400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123022400/doc4.xml","form_type":"4"}},{"id":2063818,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T19:18:19.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on February 5, 2023, and 1/12th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":50000,"derivative":{"exercise_price":0.81,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001136261-23-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626123000005/ownership.xml","form_type":"4"}},{"id":2065699,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T23:24:15.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":600000,"derivative":{"exercise_price":8.52,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001209191-23-001340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001340/doc4.xml","form_type":"4"}},{"id":2065698,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:15.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":28619,"price":8.42,"value":240971.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":2272963,"source":{"system":"sec-edgar","filing":"0001209191-23-001340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001340/doc4.xml","form_type":"4"}},{"id":2065697,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:15.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":68252,"price":8.52,"value":581507.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":2301582,"source":{"system":"sec-edgar","filing":"0001209191-23-001340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001340/doc4.xml","form_type":"4"}},{"id":2065696,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:15.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":266667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":2369834,"source":{"system":"sec-edgar","filing":"0001209191-23-001340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001340/doc4.xml","form_type":"4"}},{"id":2065695,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:15.000Z","date":"2022-12-30","kind":"tax_withholding","acquired":false,"shares":66127,"price":9.4,"value":621593.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units."}],"balance_after":2103167,"source":{"system":"sec-edgar","filing":"0001209191-23-001340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001340/doc4.xml","form_type":"4"}},{"id":2065694,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2023-01-04T23:24:15.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":121667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 66.67% of which vested on December 30, 2022 upon the achievement of two non-financial performance goals and a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on December 30, 2022 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,545 shares acquired on May 20, 2022 and 6,396 shares acquired on November 18, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":2169294,"source":{"system":"sec-edgar","filing":"0001209191-23-001340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919123001340/doc4.xml","form_type":"4"}},{"id":2442018,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T20:02:04.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on February 5, 2022, and 1/12th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":35000,"derivative":{"exercise_price":1.56,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001136261-22-000018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000113626122000018/ownership.xml","form_type":"4"}},{"id":2442773,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T00:12:12.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option will vest on each anniversary of the grant date."}],"balance_after":390000,"derivative":{"exercise_price":4.88,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001209191-22-001986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001986/doc4.xml","form_type":"4"}},{"id":2442772,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-01-06T00:12:12.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":26432,"price":4.62,"value":122115.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."}],"balance_after":2036686,"source":{"system":"sec-edgar","filing":"0001209191-22-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001986/doc4.xml","form_type":"4"}},{"id":2442771,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-01-06T00:12:12.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":173333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock unit award (\"RSU\") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award."}],"balance_after":2063118,"source":{"system":"sec-edgar","filing":"0001209191-22-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001986/doc4.xml","form_type":"4"}},{"id":2442770,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2022-01-06T00:12:12.000Z","date":"2022-01-03","kind":"tax_withholding","acquired":false,"shares":36319,"price":4.88,"value":177236.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,297 shares acquired on November 19, 2021 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":1889785,"source":{"system":"sec-edgar","filing":"0001209191-22-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919122001986/doc4.xml","form_type":"4"}},{"id":2555647,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-09-30T21:48:01.000Z","date":"2021-09-28","kind":"tax_withholding","acquired":false,"shares":27750,"price":6.5,"value":180375.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award."}],"balance_after":1924807,"source":{"system":"sec-edgar","filing":"0001209191-21-058253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121058253/doc4.xml","form_type":"4"}},{"id":2555646,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-09-30T21:48:01.000Z","date":"2021-09-28","kind":"grant","acquired":true,"shares":55500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 28, 2021 upon the achievement of a non-financial performance goal."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,876 shares acquired on May 20, 2021 pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":1952557,"source":{"system":"sec-edgar","filing":"0001209191-21-058253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121058253/doc4.xml","form_type":"4"}},{"id":2903900,"issuer":{"id":4067,"kind":"organization","name":"Viking Therapeutics, Inc."},"owners":[{"id":27973,"kind":"person","name":"Lian Brian","position":1,"cik":"0001614578","reported_name":"Lian Brian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2021-01-19T23:19:57.000Z","date":"2021-01-19","kind":"tax_withholding","acquired":false,"shares":5611,"price":6.68,"value":37481.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted\nstock units."}],"balance_after":1894181,"source":{"system":"sec-edgar","filing":"0001209191-21-004093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607678/000120919121004093/doc4.xml","form_type":"4"}}],"next_cursor":"2021-01-19T23:19:57.000000Z,2903900"}